Advertisement

Assessment of ROP Neonates

  • Ulrich Spandau
  • Sang Jin Kim
Chapter

Abstract

This chapter is about assessment of ROP neonates. The correct assessment of plus disease and of zone I or zone II is crucial for determining the correct timing and choice of treatment.

Keywords

ROP Plus disease Zone I Zone II 

References

  1. 1.
    Austeng D, Källen KB, Ewald UW, Wallin A, Holmström GE. Treatment for retinopathy of prematurity in infants born before 27 weeks of gestation in Sweden. Br J Ophthalmol. 2010;94(9):1136–9.CrossRefGoogle Scholar
  2. 2.
    Holmström G, Tornqvist K, Al-Hawasi A, Nilsson Å, Wallin A, Hellström A. Increased frequency of retinopathy of prematurity over the last decade and significant regional differences. Acta Ophthalmol. 2018 Mar;96(2):142–8.CrossRefGoogle Scholar
  3. 3.
    Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364:603–15.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Ulrich Spandau
    • 1
  • Sang Jin Kim
    • 2
  1. 1.OphthalmologyUniversity of Uppsala OphthalmologyUppsalaSweden
  2. 2.Department of OphthalmologySamsung Medical Center, Sungkyunkwan UniversitySeoulSouth Korea

Personalised recommendations